Related Experiment Video
Updated: Jun 19, 2026
08:17
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
[Radiotherapy for non-small cell lung cancer]
Nicolas Girard1, Françoise Mornex
1Service de pneumologie, hôpital Louis-Pradel, Hospices civils de Lyon, Lyon, France. nggirard@gmail.com
La Revue Du Praticien
|October 21, 2009
Summary
Radiotherapy is key for non-small cell lung cancer, especially concurrent chemoradiation for advanced tumors. Newer techniques like intensity-modulated radiotherapy and proton-beam therapy offer improved precision for specific patient groups.
Area of Science:
- Oncology
- Radiation Oncology
- Medical Physics
Context:
- Non-small cell lung cancer (NSCLC) management.
- Standard treatment for locally advanced unresectable NSCLC involves concurrent chemoradiation.
- Advancements in thoracic radiotherapy techniques are crucial for improving treatment outcomes.
Purpose:
- To review current and emerging radiotherapy modalities for non-small cell lung cancer.
- To highlight the role of concurrent chemoradiation in advanced disease.
- To discuss the potential of novel techniques in improving treatment precision and applicability.
Summary:
- Three-dimensional conformal radiotherapy allows dose escalation and combination with chemotherapy.
- Emerging techniques include respiratory gating and intensity-modulated radiotherapy for enhanced precision.
- Stereotactic radiotherapy and proton-beam radiotherapy are options for early-stage, inoperable tumors.
Impact:
- Improved therapeutic options for non-small cell lung cancer patients.
- Potential for more precise radiation delivery, minimizing side effects.
- Expanded treatment possibilities for early-stage and inoperable lung cancer.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...